This article provides a detailed resource for researchers and drug development professionals on functional Magnetic Resonance Spectroscopy (fMRS) using the MEGA-PRESS editing sequence to measure task-evoked changes in GABA and...
This article provides a comprehensive technical analysis for researchers comparing the MEGA-PRESS spectral editing technique and off-resonance acquisition for measuring glutamate (Glu) and glutamine (Gln).
This article provides a detailed exploration of MEGA-PRESS (Mescher-Garwood Point RESolved Spectroscopy) for the in-vivo detection of gamma-aminobutyric acid (GABA) in the human visual cortex.
This review synthesizes current research on the spatiotemporal progression of Lewy body pathology and its mechanistic relationship to motor symptom onset and advancement in synucleinopathies, primarily Parkinson's disease and dementia...
This article provides a comprehensive, researcher-focused analysis of LC-MS/MS versus direct ESI-MS/MS methodologies for the accurate quantification of neurotransmitters in complex biological matrices.
This article provides a detailed roadmap for researchers aiming to achieve comprehensive metabolome coverage in complex brain tissue using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
This comprehensive article explores the critical application of J-suppression (J-difference editing) pulses for resolving the overlapping glutamate (Glu) and glutamine (Gln) signals in proton magnetic resonance spectroscopy (¹H-MRS) at 7...
This article provides a comprehensive guide for researchers and drug development scientists on utilizing J-resolved Point RESolved Spectroscopy (PRESS) to accurately quantify glutamate in the nucleus accumbens (NAc).
This comprehensive guide explores the essential role of feature reduction techniques in neuroimaging analysis, tailored for researchers, scientists, and drug development professionals.
This article provides a comprehensive framework for researchers, scientists, and drug development professionals seeking to enhance the generalizability of neuroimaging findings.